Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
482 JPY
8.03 B JPY
72.04 B JPY
21.62 M
About KAKEN PHARMACEUTICAL
Sector
Headquarters
Tokyo
Founded
1917
Website
ISIN
JP3207000005
FIGI
BBG000BJWCY6
Kaken Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products, medical devices, agrochemicals, and animal health products in Japan. Its operations are carried out through the Pharmaceutical and Real Estate business segments. The Pharmaceutical segment mainly manufactures and sells pharmaceuticals, medical devices and agricultural chemicals. The Real Estate segment rents real estate related to Bunkyo Green Court. The company was founded in March 1917 and is headquartered in Tokyo, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4521 is 4,323 JPY — it has increased by 0.23% in the past 24 hours. Watch KAKEN PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange KAKEN PHARMACEUTICAL stocks are traded under the ticker 4521.
4521 stock has fallen by −2.92% compared to the previous week, the month change is a 10.14% rise, over the last year KAKEN PHARMACEUTICAL has showed a 29.55% increase.
We've gathered analysts' opinions on KAKEN PHARMACEUTICAL future price: according to them, 4521 price has a max estimate of 6,100.00 JPY and a min estimate of 3,600.00 JPY. Watch 4521 chart and read a more detailed KAKEN PHARMACEUTICAL stock forecast: see what analysts think of KAKEN PHARMACEUTICAL and suggest that you do with its stocks.
4521 reached its all-time high on Aug 18, 2015 with the price of 12,720 JPY, and its all-time low was 822 JPY and was reached on Dec 19, 2002. View more price dynamics on 4521 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4521 stock is 2.17% volatile and has beta coefficient of 0.24. Track KAKEN PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is KAKEN PHARMACEUTICAL there?
Today KAKEN PHARMACEUTICAL has the market capitalization of 163.35 B, it has increased by 1.32% over the last week.
Yes, you can track KAKEN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
KAKEN PHARMACEUTICAL is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
4521 net income for the last quarter is 12.53 B JPY, while the quarter before that showed 1.75 B JPY of net income which accounts for 614.48% change. Track more KAKEN PHARMACEUTICAL financial stats to get the full picture.
KAKEN PHARMACEUTICAL dividend yield was 4.34% in 2023, and payout ratio reached 70.54%. The year before the numbers were 4.06% and 103.60% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 30, 2024, the company has 1.14 K employees. See our rating of the largest employees — is KAKEN PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KAKEN PHARMACEUTICAL EBITDA is 26.23 B JPY, and current EBITDA margin is 17.03%. See more stats in KAKEN PHARMACEUTICAL financial statements.
Like other stocks, 4521 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KAKEN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KAKEN PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KAKEN PHARMACEUTICAL stock shows the buy signal. See more of KAKEN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.